Related Experiment Videos
Campylobacter jejuni enterocolitis presenting as inflammatory bowel disease.
C Quondamcarlo1, G Valentini, M Ruggeri
1Division of Gastroenterology and Hepatology, Regina Apostolorum Hospital, Albano Laziale, Rome, Italy.
Techniques in Coloproctology
|November 25, 2003
Summary
Campylobacter jejuni enterocolitis can mimic inflammatory bowel disease, requiring careful diagnosis. Early identification and appropriate antibiotic treatment, like erythromycin, are crucial, especially when considering corticosteroid therapy.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Internal Medicine
Background:
- Campylobacter species are a common cause of gastroenteritis.
- Campylobacter infections are often underdiagnosed.
- Campylobacter enteritis is typically self-limiting with rare complications.
Observation:
- A 19-year-old woman presented with symptoms suggestive of inflammatory bowel disease.
- Initial treatment with corticosteroids, ceftazidime, and metronidazole was ineffective.
- The patient was successfully treated with erythromycin.
Findings:
- The case highlights the challenge in differentiating infectious colitis from new-onset inflammatory bowel disease (Crohn's disease or ulcerative colitis).
- Corticosteroids, while essential for inflammatory bowel disease, can worsen infectious conditions.
- Campylobacter jejuni should be considered in the differential diagnosis of inflammatory bowel disease flares.
Implications:
- This case underscores the importance of ruling out Campylobacter jejuni in patients presenting with symptoms of inflammatory bowel disease.
- Timely diagnosis and targeted antibiotic therapy can prevent unnecessary or harmful treatments like corticosteroids.
- Awareness of atypical presentations of Campylobacter infections is vital for effective patient management.